Clinical Trials · NCT00500370
A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 163
- Start date
- Jun 2007
- Locations
- 16 sites, United States, Puerto Rico
- Primary endpoint
- Change in Body Weight